{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:03:47Z","timestamp":1794557027322,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cytomegalovirus (CMV) is a common pathogen that affects individuals of all ages and establishes lifelong latency. Although CMV is typically asymptomatic in healthy individuals, infection during pregnancy or in immunocompromised individuals can cause severe disease. Currently, treatments are limited, with no prophylactic vaccine available. Knowledge of the current epidemiologic burden of CMV is necessary to understand the need for treatment and prevention. A systematic literature review (SLR) was conducted to describe the most recent epidemiologic burden of CMV globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medline, Embase, and LILACS were searched to identify data on CMV prevalence, seroprevalence, shedding, and transmission rates. The SLR covered the time period of 2010\u20132020 and focused geographically on Australia, Europe, Israel, Japan, Latin America (LATAM), and North America. Studies were excluded if they were systematic or narrative reviews, abstracts, case series, letters, or correspondence. Studies with sample sizes\u2009&lt;\u2009100 were excluded to focus on studies with higher quality of data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-nine studies were included. Among adult men, CMV immunoglobulin G (IgG) seroprevalence ranged from 39.3% (France) to 48.0% (United States). Among women of reproductive age in Europe, Japan, LATAM, and North America, CMV IgG seroprevalence was 45.6-95.7%, 60.2%, 58.3-94.5%, and 24.6-81.0%, respectively. Seroprevalence increased with age and was lower in developed than developing countries, but data were limited. No studies of CMV immunoglobulin M (IgM) seroprevalence among men were identified. Among women of reproductive age, CMV IgM seroprevalence was heterogenous across Europe (1.0-4.6%), North America (2.3-4.5%), Japan (0.8%), and LATAM (0-0.7%). CMV seroprevalence correlated with race, ethnicity, socioeconomic status, and education level. CMV shedding ranged between 0% and 70.2% depending on age group. No findings on CMV transmission rates were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Certain populations and regions are at a substantially higher risk of CMV infection. The extensive epidemiologic burden of CMV calls for increased efforts in the research and development of vaccines and treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>N\/A.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-022-13971-7","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T09:06:47Z","timestamp":1662023207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":243,"title":["A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development"],"prefix":"10.1186","volume":"22","author":[{"given":"Karen","family":"Fowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Mucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kaczanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Grys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Natenshon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip O.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Diaz-Decaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"issue":"3","key":"13971_CR1","doi-asserted-by":"publisher","first-page":"e2034","DOI":"10.1002\/rmv.2034","volume":"29","author":"M Zuhair","year":"2019","unstructured":"Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, Griffiths P. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29(3):e2034.","journal-title":"Rev Med Virol"},{"key":"13971_CR2","volume-title":"Cytomegalovirus (CMV) and Congenital CMV Infection - Clinical Overview","author":"Centers for Disease Control and Prevention","year":"2020","unstructured":"Centers for Disease Control and Prevention. Cytomegalovirus (CMV) and Congenital CMV Infection - Clinical Overview. 2020."},{"issue":"4","key":"13971_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","volume":"20","author":"MJ Cannon","year":"2010","unstructured":"Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202\u201313.","journal-title":"Rev Med Virol"},{"issue":"9","key":"13971_CR4","doi-asserted-by":"publisher","first-page":"e13512","DOI":"10.1111\/ctr.13512","volume":"33","author":"RR Razonable","year":"2019","unstructured":"Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13512.","journal-title":"Clin Transplant"},{"issue":"3","key":"13971_CR5","first-page":"519","volume":"67","author":"GH Taylor","year":"2003","unstructured":"Taylor GH. Cytomegalovirus. Am Fam Physician. 2003;67(3):519\u201324.","journal-title":"Am Fam Physician"},{"key":"13971_CR6","doi-asserted-by":"crossref","unstructured":"Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013;57(suppl 4):S178\u2013181.","DOI":"10.1093\/cid\/cit629"},{"issue":"4","key":"13971_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/uog.23143","volume":"57","author":"D Buca","year":"2021","unstructured":"Buca D, Di Mascio D, Rizzo G, Giancotti A, D\u2019Amico A, Leombroni M, Makatsarya A, Familiari A, Liberati M, Nappi L, et al. Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021;57(4):551\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"13971_CR8","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/dmcn.13556","volume":"59","author":"MJ Korndewal","year":"2017","unstructured":"Korndewal MJ, Oudesluys-Murphy AM, Kroes ACM, van der Sande MAB, de Melker HE, Vossen A. Long-term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study. Dev Med Child Neurol. 2017;59(12):1261\u20138.","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"13971_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.544","volume":"17","author":"SC Dollard","year":"2007","unstructured":"Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355\u201363.","journal-title":"Rev Med Virol"},{"issue":"5","key":"13971_CR10","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1542\/peds.2014-1173","volume":"134","author":"J Goderis","year":"2014","unstructured":"Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134(5):972\u201382.","journal-title":"Pediatrics"},{"issue":"7","key":"13971_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/jp.2017.41","volume":"37","author":"TM Lanzieri","year":"2017","unstructured":"Lanzieri TM, Leung J, Caviness AC, Chung W, Flores M, Blum P, Bialek SR, Miller JA, Vinson SS, Turcich MR, et al. Long-term outcomes of children with symptomatic congenital cytomegalovirus disease. J Perinatol. 2017;37(7):875\u201380.","journal-title":"J Perinatol"},{"issue":"9","key":"13971_CR12","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/cid\/cit018","volume":"56","author":"CL Townsend","year":"2013","unstructured":"Townsend CL, Forsgren M, Ahlfors K, Ivarsson SA, Tookey PA, Peckham CS. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin Infect Dis. 2013;56(9):1232\u20139.","journal-title":"Clin Infect Dis"},{"key":"13971_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fmed.2020.00268","volume":"7","author":"AT Colonna","year":"2020","unstructured":"Colonna AT, Buonsenso D, Pata D, Salerno G, Chieffo DPR, Romeo DM, Faccia V, Conti G, Molle F, Baldascino A, et al. Long-term clinical, audiological, visual, neurocognitive and behavioral outcome in children with symptomatic and asymptomatic congenital cytomegalovirus infection treated with valganciclovir. Front Med (Lausanne). 2020;7:268.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"13971_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/rmv.535","volume":"17","author":"A Kenneson","year":"2007","unstructured":"Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253\u201376.","journal-title":"Rev Med Virol"},{"issue":"10","key":"13971_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJM199203053261003","volume":"326","author":"KB Fowler","year":"1992","unstructured":"Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326(10):663\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"13971_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.4437","volume":"235","author":"P Griffiths","year":"2015","unstructured":"Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol. 2015;235(2):288\u201397.","journal-title":"J Pathol"},{"issue":"6","key":"13971_CR17","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ajo.2011.11.014","volume":"153","author":"EA Sugar","year":"2012","unstructured":"Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012;153(6):1016-1024.e1015.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"13971_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/bmb\/ldz031","volume":"131","author":"BA Krishna","year":"2019","unstructured":"Krishna BA, Wills MR, Sinclair JH. Advances in the treatment of cytomegalovirus. Br Med Bull. 2019;131(1):5\u201317.","journal-title":"Br Med Bull"},{"key":"13971_CR19","doi-asserted-by":"crossref","unstructured":"Coppola T, Mangold JF, Cantrell S, Permar SR. Impact of maternal immunity on congenital cytomegalovirus birth prevalence and infant outcomes: a systematic review. Vaccines (Basel). 2019;7(4):129.","DOI":"10.3390\/vaccines7040129"},{"key":"13971_CR20","doi-asserted-by":"publisher","first-page":"104572","DOI":"10.1016\/j.micpath.2020.104572","volume":"152","author":"M Dadashi","year":"2021","unstructured":"Dadashi M, Hajikhani B, Ghazi M, Yazdani S, Goudarzi M, Nasiri MJ, Shokouhi S, Owlia P, Yaslianifard S. The global prevalence of Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus and Herpes simplex virus in patients with coronary artery disease: a systematic review and meta-analysis. Microb Pathog. 2021;152:104572.","journal-title":"Microb Pathog"},{"issue":"1","key":"13971_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00420-019-01464-x","volume":"93","author":"K Romero Starke","year":"2020","unstructured":"Romero Starke K, Kofahl M, Freiberg A, Schubert M, Gro\u00df ML, Schmauder S, Hegewald J, K\u00e4mpf D, Stranzinger J, Nienhaus A, et al. The risk of cytomegalovirus infection in daycare workers: a systematic review and meta-analysis. Int Arch Occup Environ Health. 2020;93(1):11\u201328.","journal-title":"Int Arch Occup Environ Health"},{"issue":"1","key":"13971_CR22","doi-asserted-by":"publisher","first-page":"e2011","DOI":"10.1002\/rmv.2011","volume":"29","author":"QY Zheng","year":"2019","unstructured":"Zheng QY, Huynh KT, van Zuylen WJ, Craig ME, Rawlinson WD. Cytomegalovirus infection in day care centres: A systematic review and meta-analysis of prevalence of infection in children. Rev Med Virol. 2019;29(1):e2011.","journal-title":"Rev Med Virol"},{"key":"13971_CR23","doi-asserted-by":"crossref","unstructured":"Lanzieri TM, Dollard SC, Josephson CD, Schmid DS, Bialek SR. Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics. 2013;131(6):e1937\u20131945.","DOI":"10.1542\/peds.2013-0076"},{"issue":"6","key":"13971_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/rmv.1814","volume":"24","author":"ST Hamilton","year":"2014","unstructured":"Hamilton ST, van Zuylen W, Shand A, Scott GM, Naing Z, Hall B, Craig ME, Rawlinson WD. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Rev Med Virol. 2014;24(6):420\u201333.","journal-title":"Rev Med Virol"},{"issue":"7","key":"13971_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/MAO.0000000000001861","volume":"39","author":"KT Fletcher","year":"2018","unstructured":"Fletcher KT, Horrell EMW, Ayugi J, Irungu C, Muthoka M, Creel LM, Lester C, Bush ML. The natural history and rehabilitative outcomes of hearing loss in congenital cytomegalovirus: a systematic review. Otol Neurotol. 2018;39(7):854\u201364.","journal-title":"Otol Neurotol"},{"key":"13971_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijporl.2018.10.005","volume":"115","author":"M Riga","year":"2018","unstructured":"Riga M, Korres G, Chouridis P, Naxakis S, Danielides V. Congenital cytomegalovirus infection inducing non-congenital sensorineural hearing loss during childhood; a systematic review. Int J Pediatr Otorhinolaryngol. 2018;115:156\u201364.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"13971_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","volume":"7","author":"J Styczynski","year":"2018","unstructured":"Styczynski J. Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther. 2018;7:1\u201316.","journal-title":"Infect Dis Ther"},{"key":"13971_CR28","unstructured":"Women of reproductive age (15-49 years) population [https:\/\/www.who.int\/data\/maternal-newborn-child-adolescent-ageing\/indicator-explorer-new\/mca\/women-of-reproductive-age-(15-49-years)-population-(thousands)]"},{"key":"13971_CR29","unstructured":"World Economic Outlook. April 2020. [https:\/\/www.imf.org\/external\/pubs\/ft\/weo\/2020\/01\/weodata\/groups.htm#lac]"},{"issue":"1","key":"13971_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41541-021-00316-5","volume":"6","author":"DC Kaslow","year":"2021","unstructured":"Kaslow DC. Force of infection: a determinant of vaccine efficacy? NPJ Vaccines. 2021;6(1):51.","journal-title":"NPJ Vaccines"},{"key":"13971_CR31","unstructured":"Laboratory Testing. https:\/\/www.cdc.gov\/cmv\/clinical\/lab-tests.html"},{"issue":"7","key":"13971_CR32","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1017\/S0950268817000103","volume":"145","author":"D Antona","year":"2017","unstructured":"Antona D, Lepoutre A, Fonteneau L, Baudon C, Halftermeyer-Zhou F. Y LES, L\u00e9vy-Bruhl D: Seroprevalence of cytomegalovirus infection in France in 2010. Epidemiol Infect. 2017;145(7):1471\u20138.","journal-title":"Epidemiol Infect"},{"key":"13971_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fcimb.2020.00334","volume":"10","author":"JN Styles","year":"2020","unstructured":"Styles JN, Converse RR, Griffin SM, Wade TJ, Klein E, Nylander-French LA, Stewart JR, Sams E, Hudgens E, Egorov AI. Human cytomegalovirus infections are associated with elevated biomarkers of vascular injury. Front Cell Infect Microbiol. 2020;10:334.","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"13971_CR34","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/jp.2017.133","volume":"37","author":"K Toriyabe","year":"2017","unstructured":"Toriyabe K, Morikawa F, Minematsu T, Ikejiri M, Suga S, Ikeda T. Anti-cytomegalovirus immunoglobulin M titer for congenital infection in first-trimester pregnancy with primary infection: a multicenter prospective cohort study. J Perinatol. 2017;37(12):1272\u20137.","journal-title":"J Perinatol"},{"issue":"2","key":"13971_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/INF.0000000000002510","volume":"39","author":"J Arapovi\u0107","year":"2020","unstructured":"Arapovi\u0107 J, Raji\u010d B, Pati S, Brizi\u0107 I, Azinovi\u0107 I, \u0160u\u0161ak B, Ostoji\u0107 M, Tuti\u0161 B, Ragu\u017e AB, Tomi\u0107 V, et al. Cytomegalovirus seroprevalence and birth prevalence of congenital CMV infection in Bosnia and Herzegovina: a single-center experience. Pediatr Infect Dis J. 2020;39(2):140\u20134.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"13971_CR36","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jmv.23757","volume":"86","author":"R Barlinn","year":"2014","unstructured":"Barlinn R, Vainio K, Samdal HH, Nordb\u00f8 SA, N\u00f8kleby H, Dudman SG. Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women. J Med Virol. 2014;86(5):820\u20136.","journal-title":"J Med Virol"},{"issue":"3","key":"13971_CR37","first-page":"2439","volume":"20","author":"F Gorun","year":"2020","unstructured":"Gorun F, Motoi S, Malita D, Navolan DB, Nemescu D, Olariu TR, Craina M, Vilibic-Cavlek T, Ciohat I, Boda D, et al. Cytomegalovirus seroprevalence in pregnant women in the western region of Romania: a large-scale study. Exp Ther Med. 2020;20(3):2439\u201343.","journal-title":"Exp Ther Med"},{"issue":"4","key":"13971_CR38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.5604\/01.3001.0010.7103","volume":"66","author":"D Plewik","year":"2017","unstructured":"Plewik D, Tokarska-Rodak M, Paszkiewicz J, Szepeluk A. Seroprevalence of rubella and cytomegalia in young women from Bia\u0142a Podlaska District. Pol J Microbiol. 2017;66(4):543\u20135.","journal-title":"Pol J Microbiol"},{"key":"13971_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1824-7288-40-23","volume":"40","author":"G Puccio","year":"2014","unstructured":"Puccio G, Cajozzo C, Canduscio LA, Cino L, Romano A, Schimmenti MG, Giuffr\u00e8 M, Corsello G. Epidemiology of Toxoplasma and CMV serology and of GBS colonization in pregnancy and neonatal outcome in a Sicilian population. Ital J Pediatr. 2014;40:23.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"13971_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.5604\/17331331.1227668","volume":"65","author":"J Siennicka","year":"2017","unstructured":"Siennicka J, Dunal-Szcepaniak M, Trzci\u0144ska A, Godzik P, Rosi\u0144ska M. High seroprevalence of CMV among women of childbearing age implicates high burden of congenital cytomegalovirus infection in Poland. Pol J Microbiol. 2017;65(4):425\u201332.","journal-title":"Pol J Microbiol"},{"issue":"11","key":"13971_CR41","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s10096-014-2170-3","volume":"33","author":"W Wujcicka","year":"2014","unstructured":"Wujcicka W, Gaj Z, Wilczy\u0144ski J, Sobala W, Spiewak E, Nowakowska D. Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur J Clin Microbiol Infect Dis. 2014;33(11):1951\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"13971_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/1471-2334-14-484","volume":"14","author":"C Alvarado-Esquivel","year":"2014","unstructured":"Alvarado-Esquivel C, Hern\u00e1ndez-Tinoco J, S\u00e1nchez-Anguiano LF, Ramos-Nev\u00e1rez A, Cerrillo-Soto SM, Estrada-Mart\u00ednez S, Mart\u00ednez-Ram\u00edrez L, P\u00e9rez-\u00c1lamos AR, Guido-Arreola CA. Seroepidemiology of cytomegalovirus infection in pregnant women in Durango City. Mexico BMC Infect Dis. 2014;14:484.","journal-title":"Mexico BMC Infect Dis"},{"issue":"3","key":"13971_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1556\/1886.2017.00013","volume":"7","author":"C Alvarado-Esquivel","year":"2017","unstructured":"Alvarado-Esquivel C, Sandoval-Carrillo AA, Vazquez-Alaniz F, Salas-Pacheco JM, Hern\u00e1ndez-Tinoco J, S\u00e1nchez-Anguiano LF, Antuna-Salcido EI. Lack of association between cytomegalovirus infection and hypertensive disorders in pregnancy: a case-control study in Durango, Mexico. Eur J Microbiol Immunol (Bp). 2017;7(3):229\u201333.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"4","key":"13971_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.14740\/jocmr3358w","volume":"10","author":"C Alvarado-Esquivel","year":"2018","unstructured":"Alvarado-Esquivel C, Terrones-Saldivar MDC, Hernandez-Tinoco J, Munoz-Terrones MDE, Gallegos-Gonzalez RO, Sanchez-Anguiano LF, Reyes-Robles ME, Antuna-Salcido EI. Seroepidemiology of cytomegalovirus infection in pregnant women in the Central Mexican City of Aguascalientes. J Clin Med Res. 2018;10(4):337\u201344.","journal-title":"J Clin Med Res"},{"issue":"11","key":"13971_CR45","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1128\/CVI.05228-11","volume":"18","author":"SC Dollard","year":"2011","unstructured":"Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol. 2011;18(11):1895\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"13971_CR46","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1017\/S0950268815003167","volume":"144","author":"V Lamarre","year":"2016","unstructured":"Lamarre V, Gilbert NL, Rousseau C, Gyorkos TW, Fraser WD. Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Qu\u00e9bec, 2010\u20132013. Epidemiol Infect. 2016;144(8):1701\u20139.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"13971_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12884-016-0844-9","volume":"16","author":"S Wizman","year":"2016","unstructured":"Wizman S, Lamarre V, Coic L, Kakkar F, Le Meur J-B, Rousseau C, Boucher M, Tapiero B. Awareness of cytomegalovirus and risk factors for susceptibility among pregnant women, in Montreal, Canada. BMC Pregnancy Childbirth. 2016;16(1):54.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"13971_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3923\/ijv.2011.116.122","volume":"7","author":"SES Abdel Hamid","year":"2011","unstructured":"Abdel Hamid SES, Abdel-Wahab KSE, Saleh LH, Davis GE, Hastie I, Booth JC. Comparative epidemiology of infection with human cytomegalovirus in Cairo and South London. Int J Virol. 2011;7(3):116\u201322.","journal-title":"Int J Virol"},{"issue":"7","key":"13971_CR49","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/ene.13622","volume":"25","author":"E Alari-Pahissa","year":"2018","unstructured":"Alari-Pahissa E, Moreira A, Zabalza A, Alvarez-Lafuente R, Munteis E, Vera A, Arroyo R, Alvarez-Cermeno JC, Villar LM, Lopez-Botet M, et al. Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the \u201chygiene hypothesis\u201d? Eur J Neurol. 2018;25(7):925\u201333.","journal-title":"Eur J Neurol"},{"issue":"3","key":"13971_CR50","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jinf.2019.10.017","volume":"80","author":"PAC Maple","year":"2020","unstructured":"Maple PAC, Tanasescu R, Gran B, Constantinescu CS. A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls. J Infect. 2020;80(3):320\u20135.","journal-title":"J Infect"},{"issue":"3\u20134","key":"13971_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00508-016-1069-7","volume":"129","author":"T Vilibic-Cavlek","year":"2017","unstructured":"Vilibic-Cavlek T, Kolaric B, Beader N, Vrtar I, Tabain I, Mlinaric-Galinovic G. Seroepidemiology of cytomegalovirus infections in Croatia. Wien Klin Wochenschr. 2017;129(3\u20134):129\u201335.","journal-title":"Wien Klin Wochenschr"},{"issue":"7","key":"13971_CR52","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jiac.2020.02.011","volume":"26","author":"M Takao","year":"2020","unstructured":"Takao M, Yoshioka N, Hagiya H, Deguchi M, Kagita M, Tsukamoto H, Hidaka Y, Tomono K, Tobe T. Risk for the occupational infection by cytomegalovirus among health-care workers. J Infect Chemother. 2020;26(7):681\u20134.","journal-title":"J Infect Chemother"},{"issue":"4","key":"13971_CR53","doi-asserted-by":"publisher","first-page":"314","DOI":"10.7883\/yoken.JJID.2015.366","volume":"69","author":"K Takemoto","year":"2016","unstructured":"Takemoto K, Nishimura N, Kozawa K, Hibino H, Kawaguchi M, Takeuchi S, Fujishiro N, Arai S, Gotoh K, Hosono H, et al. Time-series analysis comparing the prevalence of antibodies against nine viral species found in umbilical cord blood in Japan. Jpn J Infect Dis. 2016;69(4):314\u20138.","journal-title":"Jpn J Infect Dis"},{"issue":"3","key":"13971_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.17126\/joralres.2015.039","volume":"4","author":"C De la Tejera-Hern\u00e1ndez","year":"2015","unstructured":"De la Tejera-Hern\u00e1ndez C, Noyola D, S\u00e1nchez-Vargas L, Nava-Z\u00e1rate N, De La Cruz-Mendoza E, G\u00f3mez-Hern\u00e1ndez A, Aranda-Romo S. Analysis of risk factors associated to cytomegalovirus infection in dentistry students. J Oral Res (Impresa). 2015;4(3):197\u2013204.","journal-title":"J Oral Res (Impresa)"},{"key":"13971_CR55","doi-asserted-by":"crossref","unstructured":"Tiguman GMB, Poll LB, de Castro Alves CE, Pontes GS, Silva MT, Galvao TF. Seroprevalence of cytomegalovirus and its coinfection with Epstein-Barr virus in adult residents from Manaus: a population-based study. Revista da Sociedade Brasileira de Medicina Tropical. 2020;53:e20190363.","DOI":"10.1590\/0037-8682-0363-2019"},{"issue":"9","key":"13971_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/qjmed\/hcw026","volume":"109","author":"C Firth","year":"2016","unstructured":"Firth C, Harrison R, Ritchie S, Wardlaw J, Ferro CJ, Starr JM, Deary IJ, Moss P. Cytomegalovirus infection is associated with an increase in systolic blood pressure in older individuals. QJM. 2016;109(9):595\u2013600.","journal-title":"QJM"},{"issue":"9","key":"13971_CR57","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/1469-0691.12541","volume":"20","author":"S Gonz\u00e1lez-Quijada","year":"2014","unstructured":"Gonz\u00e1lez-Quijada S, Mora-Sim\u00f3n MJ, Martin-Ezquerro A. Association between serological evidence of past Coxiella burnetii infection and atherosclerotic cardiovascular disease in elderly patients. Clin Microbiol Infect. 2014;20(9):873\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"13971_CR58","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s12879-014-0568-2","volume":"14","author":"JD Stowell","year":"2014","unstructured":"Stowell JD, Mask K, Amin M, Clark R, Levis D, Hendley W, Lanzieri TM, Dollard SC, Cannon MJ. Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers. BMC Infect Dis. 2014;14:568.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"13971_CR59","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jcv.2014.07.020","volume":"61","author":"J Grosjean","year":"2014","unstructured":"Grosjean J, Trapes L, Hantz S, Mengelle C, Virey B, Undreiner F, Messager V, Denis F, Marin B, Alain S. Human cytomegalovirus quantification in toddlers saliva from day care centers and emergency unit: a feasibility study. J Clin Virol. 2014;61(3):371\u20137.","journal-title":"J Clin Virol"},{"issue":"5","key":"13971_CR60","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/jmv.24101","volume":"87","author":"MP Romero-G\u00f3mez","year":"2015","unstructured":"Romero-G\u00f3mez MP, Cabrera M, Montes-Bueno MT, Cendejas-Bueno E, Segovia C, Pastrana N, Mingorance J, Ome\u00f1aca F. Evaluation of cytomegalovirus infection in low-birth weight children by breast milk using a real-time polymerase chain reaction assay. J Med Virol. 2015;87(5):845\u201350.","journal-title":"J Med Virol"},{"issue":"9","key":"13971_CR61","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1093\/cid\/ciaa1168","volume":"72","author":"MR Petersen","year":"2020","unstructured":"Petersen MR, Patel EU, Abraham AG, Quinn TC, Tobian AAR. Changes in cytomegalovirus seroprevalence among U.S. children aged 1\u20135 years: the national health and nutrition examination surveys. Clin Infect Dis. 2020;72(9):e408\u201311.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"13971_CR62","doi-asserted-by":"publisher","first-page":"e2120736","DOI":"10.1001\/jamanetworkopen.2021.20736","volume":"4","author":"P Ssentongo","year":"2021","unstructured":"Ssentongo P, Hehnly C, Birungi P, Roach MA, Spady J, Fronterre C, Wang M, Murray-Kolb LE, Al-Shaar L, Chinchilli VM, et al. Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(8):e2120736.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"13971_CR63","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/00006454-199108000-00008","volume":"10","author":"SP Adler","year":"1991","unstructured":"Adler SP. Cytomegalovirus and child day care: risk factors for maternal infection. Pediatr Infect Dis J. 1991;10(8):590\u20134.","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"13971_CR64","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/jpc.13600","volume":"53","author":"WJ van Zuylen","year":"2017","unstructured":"van Zuylen WJ, Zheng QY, Hamilton ST, Egilmezer EE, Craig ME, Gralton J, Rawlinson WD. Prevalence of cytomegalovirus carriage among childcare staff. J Paediatr Child Health. 2017;53(7):724.","journal-title":"J Paediatr Child Health"},{"key":"13971_CR65","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/1471-2458-12-475","volume":"12","author":"GG van Rijckevorsel","year":"2012","unstructured":"van Rijckevorsel GG, Bovee LP, Damen M, Sonder GJ. Schim van der Loeff MF, van den Hoek A: Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care. BMC Public Health. 2012;12:475.","journal-title":"BMC Public Health"},{"issue":"3","key":"13971_CR66","doi-asserted-by":"publisher","first-page":"e0151996","DOI":"10.1371\/journal.pone.0151996","volume":"11","author":"C Wang","year":"2016","unstructured":"Wang C, Dollard SC, Amin MM, Bialek SR. Cytomegalovirus IgM seroprevalence among women of reproductive age in the United States. PLoS One. 2016;11(3):e0151996.","journal-title":"PLoS One"},{"issue":"6","key":"13971_CR67","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/CVI.00106-14","volume":"21","author":"HE Prince","year":"2014","unstructured":"Prince HE, Lape-Nixon M, Brenner A, Pitstick N, Couturier MR. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity. Clin Vaccine Immunol. 2014;21(6):813\u20136.","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"13971_CR68","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s100960000317","volume":"19","author":"Y Miendje Deyi","year":"2000","unstructured":"Miendje Deyi Y, Goubau P, Bodeus M. False-positive IgM antibody tests for cytomegalovirus in patients with acute Epstein-Barr virus infection. Eur J Clin Microbiol Infect Dis. 2000;19(7):557\u201360.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"13971_CR69","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1017\/S0950268808000551","volume":"137","author":"JB Dowd","year":"2009","unstructured":"Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect. 2009;137(1):58\u201365.","journal-title":"Epidemiol Infect"},{"issue":"12","key":"13971_CR70","doi-asserted-by":"publisher","first-page":"e016949","DOI":"10.1136\/bmjopen-2017-016949","volume":"7","author":"GM Lawrence","year":"2017","unstructured":"Lawrence GM, Friedlander Y, Calderon-Margalit R, Enquobahrie DA, Huang JY, Tracy RP, Manor O, Siscovick DS, Hochner H. Associations of social environment, socioeconomic position and social mobility with immune response in young adults: the Jerusalem Perinatal Family Follow-Up Study. BMJ Open. 2017;7(12):e016949.","journal-title":"BMJ Open"},{"issue":"12","key":"13971_CR71","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamapediatrics.2020.3009","volume":"174","author":"CJ Messinger","year":"2020","unstructured":"Messinger CJ, Lipsitch M, Bateman BT, He M, Huybrechts KF, MacDonald S, Mogun H, Mott K, Hernandez-Diaz S. Association between congenital cytomegalovirus and the prevalence at birth of microcephaly in the United States. JAMA Pediatr. 2020;174(12):1159\u201367.","journal-title":"JAMA Pediatr"},{"issue":"196\u2013201","key":"13971_CR72","first-page":"e191","volume":"200","author":"KB Fowler","year":"2018","unstructured":"Fowler KB, Ross SA, Shimamura M, Ahmed A, Palmer AL, Michaels MG, Bernstein DI, Sanchez PJ, Feja KN, Stewart A, et al. Racial and ethnic differences in the prevalence of congenital cytomegalovirus infection. J Pediatr. 2018;200(196\u2013201):e191.","journal-title":"J Pediatr"},{"key":"13971_CR73","doi-asserted-by":"crossref","unstructured":"Pribakovic JA, Katanic N, Radevic T, Tasic MS, Kostic M, Stolic B, Radulovic A, Minic V, Bojovic K, Katanic R. Serological status of childbearing-aged women for Toxoplasma gondii and cytomegalovirus in Northern Kosovo and Metohija.\u00a0Rev Soc Bras Med Trop. 2019;52:e-20170313.","DOI":"10.1590\/0037-8682-0313-2017"},{"key":"13971_CR74","doi-asserted-by":"crossref","unstructured":"De BilletteVillemeur A, Tattevin P, Salmi LR. Hygiene promotion might be better than serological screening to deal with cytomegalovirus infection during pregnancy: a methodological appraisal and decision analysis. BMC Infect Dis. 2020;20(1):418.","DOI":"10.1186\/s12879-020-05139-8"},{"issue":"4","key":"13971_CR75","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/rmv.695","volume":"21","author":"MJ Cannon","year":"2011","unstructured":"Cannon MJ, Hyde TB, Schmid DS. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol. 2011;21(4):240\u201355.","journal-title":"Rev Med Virol"},{"issue":"6","key":"13971_CR76","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/vaccines9060551","volume":"9","author":"S Scarpini","year":"2021","unstructured":"Scarpini S, Morigi F, Betti L, Dondi A, Biagi C, Lanari M. Development of a vaccine against human cytomegalovirus: advances, barriers, and implications for the clinical practice. Vaccines (Basel). 2021;9(6):551.","journal-title":"Vaccines (Basel)"},{"key":"13971_CR77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fped.2020.00013","volume":"8","author":"T Lazzarotto","year":"2020","unstructured":"Lazzarotto T, Bl\u00e1zquez-Gamero D, Delforge ML, Foulon I, Luck S, Modrow S, Leruez-Ville M. Congenital cytomegalovirus infection: a narrative review of the issues in screening and management from a panel of European experts. Front Pediatr. 2020;8:13.","journal-title":"Front Pediatr"},{"issue":"2","key":"13971_CR78","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1128\/AEM.03262-13","volume":"80","author":"JD Stowell","year":"2014","unstructured":"Stowell JD, Forlin-Passoni D, Radford K, Bate SL, Dollard SC, Bialek SR, Cannon MJ, Schmid DS. Cytomegalovirus survival and transferability and the effectiveness of common hand-washing agents against cytomegalovirus on live human hands. Appl Environ Microbiol. 2014;80(2):455\u201361.","journal-title":"Appl Environ Microbiol"},{"key":"13971_CR79","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2458-5-70","volume":"5","author":"MJ Cannon","year":"2005","unstructured":"Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health. 2005;5:70.","journal-title":"BMC Public Health"},{"issue":"1","key":"13971_CR80","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/CMR.00062-12","volume":"26","author":"S Manicklal","year":"2013","unstructured":"Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The \u201csilent\u201d global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86\u2013102.","journal-title":"Clin Microbiol Rev"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13971-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T10:05:38Z","timestamp":1662026738000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13971-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13971"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13971-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AN, CT, JD-D, and PB are employees of Moderna, Inc. and hold stock\/stock options in the company. ES, JM, MG, MK, MN, and WL are employees of Certara and were paid consultants for Moderna, Inc. for conduct of this research and development of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1659"}}